Retrieve available abstracts of 23 articles: HTML format
Single Articles
July 2025
LUO G, Yan B, Shen Y The impact and mechanism of HIV infection on tuberculous granuloma formation.
AIDS. 2025;39:1095-1105. PubMedAbstract available
April 2025
ELLIS J, Dai B, Kabahubya M, Hale G, et al Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst
hospitalized adults with advanced HIV disease: a prospective cohort study.
AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004213. PubMedAbstract available
October 2024
CHAISSON LH, Durovni B, Umar N, Cohn S, et al Sex differences in tuberculosis infection and disease among people with HIV.
AIDS. 2024 Oct 25. doi: 10.1097/QAD.0000000000004045. PubMedAbstract available
SUMNER T, Clark RA, Prys-Jones TO, Bakker R, et al The potential impact of new TB vaccines on the burden of TB in people living with
HIV in South Africa.
AIDS. 2024 Oct 11. doi: 10.1097/QAD.0000000000004038. PubMedAbstract available
April 2024
DERSEH NM, Agimas MC, Tesfie TK Risk score prediction for bacteriologically confirmed tuberculosis among
HIV-infected adults on antiretroviral therapy in Ethiopia: prognostic model
development.
AIDS. 2024 Apr 25. doi: 10.1097/QAD.0000000000003917. PubMedAbstract available
March 2024
HU FH, Tang XL, Ge MW, Jia YJ, et al Mortality of children and adolescents co-infected with tuberculosis and HIV: a
systematic review and meta-analysis.
AIDS. 2024 Mar 18. doi: 10.1097/QAD.0000000000003886. PubMedAbstract available
January 2024
TSUKAMOTO T, Winslow DL Predicting tuberculosis at antiretroviral therapy initiation: the combination of
monocyte-to-lymphocyte ratio and hemoglobin level may be a key.
AIDS. 2024;38:115-117. PubMed
November 2023
CHERKOS AS, Cranmer LM, Njuguna I, LaCourse SM, et al Effect of TB-HIV co-treatment on clinical and growth outcomes among hospitalized
children newly initiating antiretroviral therapy.
AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003797. PubMedAbstract available
PETERSON M, Briceno-Robaugh R, O'Connor S, Date A, et al Quantifying missed opportunities for tuberculosis among people with HIV in the US
President's Emergency Plan for AIDS Relief.
AIDS. 2023;37:2103-2104. PubMed
October 2023
VAN GEUNS D, Arts RJ, de Vries G, Wit FW, et al Screening for tuberculosis infection and effectiveness of preventive treatment
among people living with HIV in low-incidence settings: a systematic review and
meta-analysis.
AIDS. 2023 Oct 12. doi: 10.1097/QAD.0000000000003747. PubMedAbstract available
NIYONGABO B, Hira S Evaluation of the diagnostic efficacy of EC-test for latent tuberculosis
infection in ambulatory people with HIV.
AIDS. 2023;37:1899-1900. PubMed
VENTER F, Niyongabo B Tuberculosis-HIV co-infection in an era of complex, rapid new drug development.
AIDS. 2023;37:1897-1898. PubMed
September 2023
ONYANGO DO, van der Sande MAB, Yuen CM, Were J, et al Biomarker-confirmed suboptimal adherence to isoniazid preventive therapy among
children living with HIV in western Kenya.
AIDS. 2023 Sep 29. doi: 10.1097/QAD.0000000000003719. PubMedAbstract available
GATECHOMPOL S, Kerr SJ, Cardoso SW, Samaneka W, et al Monocyte to lymphocyte ratio and hemoglobin level to predict tuberculosis after
antiretroviral therapy initiation.
AIDS. 2023 Sep 11. doi: 10.1097/QAD.0000000000003713. PubMedAbstract available
HONG H, Dill-Mcfarland KA, Benson B, Simmons JD, et al Mtb-induced Monocyte Transcriptional Responses Associate with Resistance to
TST/IGRA Conversion in PLWH.
AIDS. 2023 Sep 11. doi: 10.1097/QAD.0000000000003716. PubMedAbstract available
August 2023
BALASUBRAMANIAN R, Shearer K, Mudzengi D, Hippner P, et al Modeling the impact of universal TB molecular testing and timing of TB preventive
treatment during ART initiation in South Africa.
AIDS. 2023 Aug 30. doi: 10.1097/QAD.0000000000003707. PubMedAbstract available
July 2023
KRAEF C, Bentzon A, Roen A, Bolokadze N, et al Long-term outcomes after tuberculosis for people with HIV in eastern Europe.
AIDS. 2023 Jul 28. doi: 10.1097/QAD.0000000000003670. PubMedAbstract available
June 2023
MASSMANN R, Groh T, Jilich D, Bartkova D, et al HIV-positive Ukrainian refugees in the Czech Republic: a retrospective,
observational study.
AIDS. 2023 Jun 22. doi: 10.1097/QAD.0000000000003633. PubMedAbstract available
May 2023
HAHN JA, Ngabirano C, Fatch R, Emenyonu NI, et al Safety and tolerability of isoniazid preventive therapy for tuberculosis for
persons with HIV with and without alcohol use: a single arm trial.
AIDS. 2023 May 30. doi: 10.1097/QAD.0000000000003613. PubMedAbstract available
April 2023
CHONGXING Z, Yuanchun L, Yan H, Dabin L, et al Evaluation of the Diagnostic Efficacy of EC-Test for Latent Tuberculosis
Infection in Ambulatory People Living with HIV.
AIDS. 2023 Apr 20. doi: 10.1097/QAD.0000000000003573. PubMedAbstract available
March 2023
TEMU TM, Polyak SJ, Wanjalla CN, Mandela NA, et al Latent tuberculosis is associated with heightened levels of pro-and
anti-inflammatory cytokines among Kenyan men and women living with HIV on
long-term antiretroviral therapy.
AIDS. 2023 Mar 6. doi: 10.1097/QAD.0000000000003523. PubMedAbstract available
February 2023
DE CASTRO N, Chazallon C, Brites C, Messou E, et al Virologic response to antiretroviral therapy in people with HIV and tuberculosis
in high-TB burden countries.
AIDS. 2023 Feb 17. doi: 10.1097/QAD.0000000000003521. PubMedAbstract available
CHAISSON LH, Semitala FC, Nangobi F, Steinmetz S, et al Viral suppression among adults with HIV receiving routine dolutegravir-based
antiretroviral therapy and 3HP.
AIDS. 2023 Feb 8. doi: 10.1097/QAD.0000000000003508. PubMedAbstract available